A61K 31/539
Having two or more oxygen atoms in the same ring
Official title: having two or more oxygen atoms in the same ring, e.g. dioxazines
A61K31/539 (Having two or more oxygen atoms in the same ring) appears on 6 US grants and 12 published applications in this corpus.
Search patents in A61K- Granted patents
- 6
- Published applications
- 12
- Assignees
- 11
- Inventors
- 38
- Latest grant
- 13 Jul 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 3 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 3 |
By publication year.
Recent patents
- Use of cytochrome bc1 complex inhibitor in preparing pharmaceutical composition13 Jul 2021US 11,058,690 B2Beijing Weilanzhiyuan Medical Technology Co., Ltd.
- Benzoxazinone derivatives for treatment of skin diseases11 Sep 2018US 10,072,024 B2Sixera Pharma AB
- Benzoxazinone derivatives for treatment of skin diseases4 Jul 2017US 9,695,194 B2Sixera Pharma AB
- Use of fungicides for the treatment of fish mycoses4 Jun 2013US 8,455,481 B2Bayer CropScience AG
- Use of fungicides for the treatment of fish mycoses13 Dec 2011US 8,076,328 B2Bayer CropScience AG
- Dioxazines and their use in treatment of gba-related diseases28 Nov 2024US 2024/0390383 A1Zevra Denmark A/S
- Method for Producing Cardiomyocytes by Means of Reprogramming21 Nov 2024US 2024/0384233 A1Peking University
- Substituted acyl sulfonamides for treating cancer22 Aug 2024US 2024/0279207 A1Bayer Aktiengesellschaft
- Superior efficacy of azoxystrobin and other strobilurins23 Jun 2022US 2022/0192956 A1The Procter & Gamble Company
- Use of cytochrome bc1 complex inhibitor in preparing pharmaceutical composition19 Dec 2019US 2019/0381055 A1Beijing Weilanzhiyuan Medical Technology Co., Ltd.
Most cited
By later US patents